Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 1995.3 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 3162.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 15848.9 | nM | PubChem BioAssay data set | |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 22334.2 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 6513.1 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC87043 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC476420 |
0.8696 | High Similarity | NPC266245 |
0.8657 | High Similarity | NPC87224 |
0.8657 | High Similarity | NPC222572 |
0.8611 | High Similarity | NPC229190 |
0.8571 | High Similarity | NPC207179 |
0.8571 | High Similarity | NPC167571 |
0.8571 | High Similarity | NPC278552 |
0.855 | High Similarity | NPC190454 |
0.855 | High Similarity | NPC97432 |
0.85 | High Similarity | NPC294456 |
0.85 | High Similarity | NPC212124 |
0.85 | High Similarity | NPC225106 |
0.85 | High Similarity | NPC184861 |
0.85 | High Similarity | NPC309452 |
0.85 | High Similarity | NPC281014 |
0.8467 | Intermediate Similarity | NPC162801 |
0.8451 | Intermediate Similarity | NPC195357 |
0.8451 | Intermediate Similarity | NPC152771 |
0.844 | Intermediate Similarity | NPC279573 |
0.8435 | Intermediate Similarity | NPC241636 |
0.8429 | Intermediate Similarity | NPC224543 |
0.8429 | Intermediate Similarity | NPC78746 |
0.8429 | Intermediate Similarity | NPC188380 |
0.8425 | Intermediate Similarity | NPC472918 |
0.8417 | Intermediate Similarity | NPC117048 |
0.8417 | Intermediate Similarity | NPC124085 |
0.8414 | Intermediate Similarity | NPC212697 |
0.838 | Intermediate Similarity | NPC312881 |
0.8378 | Intermediate Similarity | NPC267117 |
0.8369 | Intermediate Similarity | NPC232246 |
0.8369 | Intermediate Similarity | NPC153818 |
0.8358 | Intermediate Similarity | NPC98509 |
0.8357 | Intermediate Similarity | NPC33986 |
0.8356 | Intermediate Similarity | NPC148011 |
0.8356 | Intermediate Similarity | NPC1940 |
0.8345 | Intermediate Similarity | NPC215037 |
0.8345 | Intermediate Similarity | NPC92805 |
0.8345 | Intermediate Similarity | NPC85435 |
0.8333 | Intermediate Similarity | NPC29734 |
0.8333 | Intermediate Similarity | NPC103799 |
0.8333 | Intermediate Similarity | NPC150023 |
0.8322 | Intermediate Similarity | NPC287286 |
0.8322 | Intermediate Similarity | NPC471229 |
0.8311 | Intermediate Similarity | NPC277032 |
0.831 | Intermediate Similarity | NPC151946 |
0.831 | Intermediate Similarity | NPC211110 |
0.8299 | Intermediate Similarity | NPC44721 |
0.8299 | Intermediate Similarity | NPC3779 |
0.8299 | Intermediate Similarity | NPC476182 |
0.8299 | Intermediate Similarity | NPC176869 |
0.8299 | Intermediate Similarity | NPC122828 |
0.8299 | Intermediate Similarity | NPC211466 |
0.8299 | Intermediate Similarity | NPC40086 |
0.8298 | Intermediate Similarity | NPC38099 |
0.8298 | Intermediate Similarity | NPC26954 |
0.8298 | Intermediate Similarity | NPC20829 |
0.8298 | Intermediate Similarity | NPC262585 |
0.8298 | Intermediate Similarity | NPC18189 |
0.8298 | Intermediate Similarity | NPC3049 |
0.8288 | Intermediate Similarity | NPC142731 |
0.8288 | Intermediate Similarity | NPC279417 |
0.8288 | Intermediate Similarity | NPC306607 |
0.8288 | Intermediate Similarity | NPC326506 |
0.8288 | Intermediate Similarity | NPC208176 |
0.8288 | Intermediate Similarity | NPC49130 |
0.8288 | Intermediate Similarity | NPC62290 |
0.8288 | Intermediate Similarity | NPC4152 |
0.8286 | Intermediate Similarity | NPC98179 |
0.8286 | Intermediate Similarity | NPC253574 |
0.8284 | Intermediate Similarity | NPC38761 |
0.8284 | Intermediate Similarity | NPC76465 |
0.8276 | Intermediate Similarity | NPC471824 |
0.8273 | Intermediate Similarity | NPC280476 |
0.8273 | Intermediate Similarity | NPC281558 |
0.8273 | Intermediate Similarity | NPC119985 |
0.8271 | Intermediate Similarity | NPC54972 |
0.8261 | Intermediate Similarity | NPC113098 |
0.8261 | Intermediate Similarity | NPC146615 |
0.8258 | Intermediate Similarity | NPC93398 |
0.8258 | Intermediate Similarity | NPC258979 |
0.8258 | Intermediate Similarity | NPC8283 |
0.8255 | Intermediate Similarity | NPC116822 |
0.8248 | Intermediate Similarity | NPC47283 |
0.8248 | Intermediate Similarity | NPC39064 |
0.8243 | Intermediate Similarity | NPC287294 |
0.8239 | Intermediate Similarity | NPC474687 |
0.8239 | Intermediate Similarity | NPC155963 |
0.8235 | Intermediate Similarity | NPC471215 |
0.8235 | Intermediate Similarity | NPC50315 |
0.8235 | Intermediate Similarity | NPC230479 |
0.8235 | Intermediate Similarity | NPC26879 |
0.8235 | Intermediate Similarity | NPC283049 |
0.8235 | Intermediate Similarity | NPC262573 |
0.8227 | Intermediate Similarity | NPC151224 |
0.8227 | Intermediate Similarity | NPC164787 |
0.8227 | Intermediate Similarity | NPC472525 |
0.8219 | Intermediate Similarity | NPC469701 |
0.8214 | Intermediate Similarity | NPC318400 |
0.8214 | Intermediate Similarity | NPC163557 |
0.8214 | Intermediate Similarity | NPC167111 |
0.8214 | Intermediate Similarity | NPC296624 |
0.8214 | Intermediate Similarity | NPC207002 |
0.8214 | Intermediate Similarity | NPC471910 |
0.8214 | Intermediate Similarity | NPC133956 |
0.8214 | Intermediate Similarity | NPC469449 |
0.8212 | Intermediate Similarity | NPC203080 |
0.8212 | Intermediate Similarity | NPC141212 |
0.8209 | Intermediate Similarity | NPC100099 |
0.8209 | Intermediate Similarity | NPC36016 |
0.8207 | Intermediate Similarity | NPC135767 |
0.8207 | Intermediate Similarity | NPC155392 |
0.8207 | Intermediate Similarity | NPC274721 |
0.8201 | Intermediate Similarity | NPC272650 |
0.8201 | Intermediate Similarity | NPC267336 |
0.8201 | Intermediate Similarity | NPC250727 |
0.8194 | Intermediate Similarity | NPC476442 |
0.8194 | Intermediate Similarity | NPC215512 |
0.8182 | Intermediate Similarity | NPC287068 |
0.8182 | Intermediate Similarity | NPC475836 |
0.8182 | Intermediate Similarity | NPC160972 |
0.8182 | Intermediate Similarity | NPC295259 |
0.8176 | Intermediate Similarity | NPC14875 |
0.8176 | Intermediate Similarity | NPC169510 |
0.8169 | Intermediate Similarity | NPC230734 |
0.8169 | Intermediate Similarity | NPC474639 |
0.8169 | Intermediate Similarity | NPC302701 |
0.8169 | Intermediate Similarity | NPC269091 |
0.8169 | Intermediate Similarity | NPC227503 |
0.8163 | Intermediate Similarity | NPC268515 |
0.8163 | Intermediate Similarity | NPC40222 |
0.8162 | Intermediate Similarity | NPC285040 |
0.8162 | Intermediate Similarity | NPC188022 |
0.8162 | Intermediate Similarity | NPC103420 |
0.8162 | Intermediate Similarity | NPC17809 |
0.8162 | Intermediate Similarity | NPC168259 |
0.8162 | Intermediate Similarity | NPC102540 |
0.8156 | Intermediate Similarity | NPC100986 |
0.8156 | Intermediate Similarity | NPC267412 |
0.8156 | Intermediate Similarity | NPC326600 |
0.8156 | Intermediate Similarity | NPC50896 |
0.8156 | Intermediate Similarity | NPC166672 |
0.8156 | Intermediate Similarity | NPC213173 |
0.8156 | Intermediate Similarity | NPC62366 |
0.8156 | Intermediate Similarity | NPC84894 |
0.8156 | Intermediate Similarity | NPC198381 |
0.8156 | Intermediate Similarity | NPC195343 |
0.8156 | Intermediate Similarity | NPC127888 |
0.8156 | Intermediate Similarity | NPC224475 |
0.8156 | Intermediate Similarity | NPC287182 |
0.8156 | Intermediate Similarity | NPC74655 |
0.8156 | Intermediate Similarity | NPC47163 |
0.8156 | Intermediate Similarity | NPC164269 |
0.8156 | Intermediate Similarity | NPC18804 |
0.8156 | Intermediate Similarity | NPC180716 |
0.8156 | Intermediate Similarity | NPC319859 |
0.8156 | Intermediate Similarity | NPC260265 |
0.8156 | Intermediate Similarity | NPC204353 |
0.8151 | Intermediate Similarity | NPC44530 |
0.8151 | Intermediate Similarity | NPC317237 |
0.8151 | Intermediate Similarity | NPC277951 |
0.8148 | Intermediate Similarity | NPC474160 |
0.8146 | Intermediate Similarity | NPC473996 |
0.8146 | Intermediate Similarity | NPC243171 |
0.8146 | Intermediate Similarity | NPC210597 |
0.8146 | Intermediate Similarity | NPC35567 |
0.8146 | Intermediate Similarity | NPC171651 |
0.8143 | Intermediate Similarity | NPC194277 |
0.8143 | Intermediate Similarity | NPC202762 |
0.8143 | Intermediate Similarity | NPC61477 |
0.8143 | Intermediate Similarity | NPC261619 |
0.8143 | Intermediate Similarity | NPC126029 |
0.8143 | Intermediate Similarity | NPC13005 |
0.8143 | Intermediate Similarity | NPC78770 |
0.8143 | Intermediate Similarity | NPC86655 |
0.8143 | Intermediate Similarity | NPC219876 |
0.8143 | Intermediate Similarity | NPC15658 |
0.8143 | Intermediate Similarity | NPC185604 |
0.8134 | Intermediate Similarity | NPC193364 |
0.8121 | Intermediate Similarity | NPC218569 |
0.8116 | Intermediate Similarity | NPC274717 |
0.8116 | Intermediate Similarity | NPC226331 |
0.8116 | Intermediate Similarity | NPC219923 |
0.8116 | Intermediate Similarity | NPC53986 |
0.8116 | Intermediate Similarity | NPC38664 |
0.8116 | Intermediate Similarity | NPC46274 |
0.8112 | Intermediate Similarity | NPC471069 |
0.8112 | Intermediate Similarity | NPC471068 |
0.8108 | Intermediate Similarity | NPC296377 |
0.8108 | Intermediate Similarity | NPC30720 |
0.8106 | Intermediate Similarity | NPC74821 |
0.8105 | Intermediate Similarity | NPC474638 |
0.8102 | Intermediate Similarity | NPC276212 |
0.8099 | Intermediate Similarity | NPC472424 |
0.8099 | Intermediate Similarity | NPC94750 |
0.8099 | Intermediate Similarity | NPC61946 |
0.8099 | Intermediate Similarity | NPC281241 |
0.8099 | Intermediate Similarity | NPC471909 |
0.8099 | Intermediate Similarity | NPC112939 |
0.8099 | Intermediate Similarity | NPC86892 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC87043 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8143 | Intermediate Similarity | NPD1613 | Approved |
0.8143 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8134 | Intermediate Similarity | NPD1610 | Phase 2 |
0.8116 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8106 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8043 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8 | Intermediate Similarity | NPD422 | Phase 1 |
0.7986 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7931 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7931 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7872 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7832 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7832 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7823 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7821 | Intermediate Similarity | NPD7075 | Discontinued |
0.78 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD1934 | Approved |
0.7778 | Intermediate Similarity | NPD4380 | Phase 2 |
0.777 | Intermediate Similarity | NPD3750 | Approved |
0.7755 | Intermediate Similarity | NPD2424 | Discontinued |
0.7754 | Intermediate Similarity | NPD4749 | Approved |
0.7742 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7733 | Intermediate Similarity | NPD6799 | Approved |
0.7707 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7671 | Intermediate Similarity | NPD1510 | Phase 2 |
0.766 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7647 | Intermediate Similarity | NPD1653 | Approved |
0.7643 | Intermediate Similarity | NPD3882 | Suspended |
0.7632 | Intermediate Similarity | NPD1512 | Approved |
0.7628 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7609 | Intermediate Similarity | NPD1091 | Approved |
0.7582 | Intermediate Similarity | NPD5403 | Approved |
0.7566 | Intermediate Similarity | NPD5401 | Approved |
0.7564 | Intermediate Similarity | NPD6801 | Discontinued |
0.7552 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7548 | Intermediate Similarity | NPD6599 | Discontinued |
0.7533 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7517 | Intermediate Similarity | NPD1240 | Approved |
0.75 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1511 | Approved |
0.7466 | Intermediate Similarity | NPD4340 | Discontinued |
0.7451 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7432 | Intermediate Similarity | NPD3748 | Approved |
0.7431 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7415 | Intermediate Similarity | NPD1607 | Approved |
0.7405 | Intermediate Similarity | NPD2801 | Approved |
0.7397 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7394 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7389 | Intermediate Similarity | NPD7411 | Suspended |
0.7383 | Intermediate Similarity | NPD2796 | Approved |
0.7379 | Intermediate Similarity | NPD6798 | Discontinued |
0.7358 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7358 | Intermediate Similarity | NPD5402 | Approved |
0.7348 | Intermediate Similarity | NPD2684 | Approved |
0.7333 | Intermediate Similarity | NPD3751 | Discontinued |
0.7333 | Intermediate Similarity | NPD3818 | Discontinued |
0.7324 | Intermediate Similarity | NPD8651 | Approved |
0.7305 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD290 | Approved |
0.7267 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7267 | Intermediate Similarity | NPD6100 | Approved |
0.7267 | Intermediate Similarity | NPD3749 | Approved |
0.7267 | Intermediate Similarity | NPD6099 | Approved |
0.7262 | Intermediate Similarity | NPD6559 | Discontinued |
0.7259 | Intermediate Similarity | NPD7843 | Approved |
0.725 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD2800 | Approved |
0.723 | Intermediate Similarity | NPD6355 | Discontinued |
0.7226 | Intermediate Similarity | NPD6671 | Approved |
0.7219 | Intermediate Similarity | NPD5762 | Approved |
0.7219 | Intermediate Similarity | NPD5763 | Approved |
0.7211 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7206 | Intermediate Similarity | NPD1241 | Discontinued |
0.7203 | Intermediate Similarity | NPD3225 | Approved |
0.7202 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7188 | Intermediate Similarity | NPD7819 | Suspended |
0.7161 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7161 | Intermediate Similarity | NPD7213 | Phase 3 |
0.716 | Intermediate Similarity | NPD7251 | Discontinued |
0.7143 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7143 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7123 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7118 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7118 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7115 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7101 | Intermediate Similarity | NPD7157 | Approved |
0.7099 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7086 | Intermediate Similarity | NPD5588 | Approved |
0.7086 | Intermediate Similarity | NPD7033 | Discontinued |
0.7083 | Intermediate Similarity | NPD7054 | Approved |
0.7081 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7078 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7078 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD7095 | Approved |
0.7073 | Intermediate Similarity | NPD5494 | Approved |
0.7068 | Intermediate Similarity | NPD968 | Approved |
0.7063 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7048 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7042 | Intermediate Similarity | NPD3496 | Discontinued |
0.7041 | Intermediate Similarity | NPD7472 | Approved |
0.7034 | Intermediate Similarity | NPD2797 | Approved |
0.7027 | Intermediate Similarity | NPD3268 | Approved |
0.7023 | Intermediate Similarity | NPD846 | Approved |
0.7023 | Intermediate Similarity | NPD940 | Approved |
0.702 | Intermediate Similarity | NPD4538 | Approved |
0.702 | Intermediate Similarity | NPD4536 | Approved |
0.702 | Intermediate Similarity | NPD7097 | Phase 1 |
0.702 | Intermediate Similarity | NPD4537 | Clinical (unspecified phase) |
0.7015 | Intermediate Similarity | NPD1358 | Approved |
0.7014 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6988 | Remote Similarity | NPD3787 | Discontinued |
0.6987 | Remote Similarity | NPD5058 | Phase 3 |
0.6986 | Remote Similarity | NPD6917 | Clinical (unspecified phase) |
0.6982 | Remote Similarity | NPD5844 | Phase 1 |
0.6974 | Remote Similarity | NPD5960 | Phase 3 |
0.6972 | Remote Similarity | NPD6516 | Phase 2 |
0.6972 | Remote Similarity | NPD5846 | Approved |
0.6948 | Remote Similarity | NPD970 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD2415 | Discontinued |
0.6928 | Remote Similarity | NPD7199 | Phase 2 |
0.6928 | Remote Similarity | NPD1247 | Approved |
0.6928 | Remote Similarity | NPD6959 | Discontinued |
0.6923 | Remote Similarity | NPD6190 | Approved |
0.6919 | Remote Similarity | NPD7549 | Discontinued |
0.6918 | Remote Similarity | NPD1203 | Approved |
0.6918 | Remote Similarity | NPD920 | Approved |
0.6909 | Remote Similarity | NPD919 | Approved |
0.6899 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD8055 | Clinical (unspecified phase) |
0.6887 | Remote Similarity | NPD230 | Phase 1 |
0.6884 | Remote Similarity | NPD5535 | Approved |
0.6883 | Remote Similarity | NPD6005 | Phase 3 |
0.6883 | Remote Similarity | NPD6002 | Phase 3 |
0.6883 | Remote Similarity | NPD6004 | Phase 3 |
0.6883 | Remote Similarity | NPD6003 | Clinical (unspecified phase) |
0.6883 | Remote Similarity | NPD6006 | Clinical (unspecified phase) |
0.6883 | Remote Similarity | NPD7266 | Discontinued |
0.6879 | Remote Similarity | NPD643 | Clinical (unspecified phase) |
0.6867 | Remote Similarity | NPD4062 | Phase 3 |
0.6866 | Remote Similarity | NPD9697 | Approved |
0.6863 | Remote Similarity | NPD4308 | Phase 3 |
0.6859 | Remote Similarity | NPD7466 | Approved |
0.6859 | Remote Similarity | NPD3892 | Phase 2 |
0.6855 | Remote Similarity | NPD7314 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD6651 | Approved |
0.6842 | Remote Similarity | NPD6653 | Approved |
0.6829 | Remote Similarity | NPD4288 | Approved |
0.6828 | Remote Similarity | NPD9717 | Approved |
0.6824 | Remote Similarity | NPD3018 | Phase 2 |
0.6818 | Remote Similarity | NPD2935 | Discontinued |
0.6815 | Remote Similarity | NPD2354 | Approved |
0.6815 | Remote Similarity | NPD3134 | Approved |
0.6812 | Remote Similarity | NPD228 | Approved |
0.6807 | Remote Similarity | NPD6234 | Discontinued |
0.6803 | Remote Similarity | NPD3267 | Approved |
0.6803 | Remote Similarity | NPD987 | Approved |
0.6803 | Remote Similarity | NPD3266 | Approved |
0.68 | Remote Similarity | NPD3764 | Approved |
0.68 | Remote Similarity | NPD1048 | Approved |
0.68 | Remote Similarity | NPD2313 | Discontinued |
0.6795 | Remote Similarity | NPD1243 | Approved |
0.6792 | Remote Similarity | NPD2534 | Approved |
0.6792 | Remote Similarity | NPD2532 | Approved |
0.6792 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6792 | Remote Similarity | NPD2533 | Approved |
0.6781 | Remote Similarity | NPD6582 | Phase 2 |
0.6781 | Remote Similarity | NPD6583 | Phase 3 |
0.6776 | Remote Similarity | NPD5735 | Approved |
0.6774 | Remote Similarity | NPD2344 | Approved |
0.6768 | Remote Similarity | NPD8455 | Phase 2 |
0.6759 | Remote Similarity | NPD1535 | Discovery |
0.6757 | Remote Similarity | NPD5647 | Approved |
0.675 | Remote Similarity | NPD5049 | Phase 3 |
0.6748 | Remote Similarity | NPD5090 | Approved |
0.6748 | Remote Similarity | NPD5089 | Approved |
0.6746 | Remote Similarity | NPD3926 | Phase 2 |
0.6736 | Remote Similarity | NPD4626 | Approved |
0.6735 | Remote Similarity | NPD6696 | Suspended |
0.673 | Remote Similarity | NPD4357 | Discontinued |
0.6713 | Remote Similarity | NPD9545 | Approved |
0.6713 | Remote Similarity | NPD1894 | Discontinued |
0.6712 | Remote Similarity | NPD1481 | Phase 2 |
0.6711 | Remote Similarity | NPD4140 | Approved |
0.6711 | Remote Similarity | NPD943 | Approved |
0.6708 | Remote Similarity | NPD6980 | Clinical (unspecified phase) |
0.6707 | Remote Similarity | NPD37 | Approved |
0.6706 | Remote Similarity | NPD2403 | Approved |
0.6688 | Remote Similarity | NPD2200 | Suspended |
0.6687 | Remote Similarity | NPD4965 | Approved |
0.6687 | Remote Similarity | NPD4966 | Approved |
PubChem CID   | |
ChEMBL   | CHEMBL1439718 |
ZINC   |
Molecular Weight:   | 284.07 |
ALogP:   | -1.1438 |
MLogP:   | 2.67 |
XLogP:   | 0.153 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 86.99 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 3 |
# Rings:   | 4 |
# Heavy Atoms:   | 21 |